InsidersTradesSigma
Track the 디알텍 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 디알텍 has recorded 41 insider filings. Market capitalisation: €67bn. The latest transaction was disclosed on 23 June 2026 (Other). Among the most active insiders: 윤정기. Every trade is openly available.
41
Insider Decl.
n/a
Thresholds
€5,735
16 ops.
Buy Volume
n/a
8 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,557 of 29,057 companies
16.1
score / 100
Value7
Quality25
FCF yld-34%
Earn yld-30%
EV/EBITDA·
ROE-16%
Gross mgn36%
Net mgn-21%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 June 2026
Declarations41 total
5,591,277 sharesKRXDART:20240528000432
25 of 41 declarations
Acerca de 디알텍
디알텍 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el campo médico.